Cleared Traditional

CCG CERCLAGE SYSTEM (K932024) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K932024 · Encore Orthopedics, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
659d
Days
Class 2
Risk

K932024 is an FDA 510(k) clearance for the CCG CERCLAGE SYSTEM. Classified as Cerclage, Fixation (product code JDQ), Class II - Special Controls.

Submitted by Encore Orthopedics, Inc. (Austin, US). The FDA issued a Cleared decision on February 14, 1995 after a review of 659 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3010 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Encore Orthopedics, Inc. devices

Submission Details

510(k) Number K932024 FDA.gov
FDA Decision Cleared Substantially Equivalent - NSE Converted (SN)
Date Received April 26, 1993
Decision Date February 14, 1995
Days to Decision 659 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
537d slower than avg
Panel avg: 122d · This submission: 659d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JDQ Cerclage, Fixation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3010
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - JDQ Cerclage, Fixation

All 53
Devices cleared under the same product code (JDQ) and FDA review panel - the closest regulatory comparables to K932024.
SYNTHES WIRE MOUNT
K953777 · Synthes (Usa) · Mar 1996
DALL-MILES SUTURE/BEADED CABLE
K953818 · Howmedica Corp. · Oct 1995
DALL MILES SYSTEM HOMOGENEOUS VITALLIUM CABLE
K945294 · Howmedica Corp. · Mar 1995
DALL MILES SYSTEM GROOVED BUTTON
K934059 · Howmedica Corp. · Aug 1994
CONTROL CABLE SYSTEM
K934557 · Depuy, Inc. · Feb 1994
DALL MILES SYSTEM MINICLEAT
K934058 · Howmedica Corp. · Feb 1994